Alzinova: Completes Preclinical Humanization of ALZ-201 - Redeye
Redeye is encouraged by the news that Alzinova has successfully completed the humanization work, and selected a humanized lead candidate, of its monoclonal antibody ALZ-201.
ANNONS
Redeye is encouraged by the news that Alzinova has successfully completed the humanization work, and selected a humanized lead candidate, of its monoclonal antibody ALZ-201.